10 Yaz Lawsuits Join Coordinated Proceedings in California
Recently 10 new plaintiffs have filed a Yaz lawsuit over the drug’s side effects. This lawsuit has joined other similar cases in a coordinated proceeding in Los Angeles County Superior Court and focuses on the dangers linked to Yaz, Yasmin and the generic version of the pills, Ocella.
In this lawsuit, the plaintiffs suffered from blood clot-related injuries including pulmonary embolisms and deep vein thrombosis. The plaintiffs all hail from different parts of the country, including Oregon, Ohio, Texas and California. In the complaint, all of the women state that they took brand name and generic versions of Yaz or Yasmin between 2005 and 2012. Each plaintiff also claims that she was not properly warned of the dangers linked to Yaz use before she took the medication.
While the women in these lawsuits suffered from injuries related to blood clots, other side effects have been linked to Yaz, as well. Some of those injuries include heart attacks, strokes, kidney stones, irritable bowel syndrome and gallbladder disease. Since the pills hit the market, Bayer, the makers of Yaz, has been sued by more than 14,000 former users — and the list continues to grow. Bayer has been accused of knowingly hiding Yaz dangers from the public for years. The company long denied that the pills are any more dangerous than older birth control pills, but then it started conceding the dangers earlier this year by agreeing to financial settlements with as much as 3,400 plaintiffs to the tune of $750 million. With more than 14,000 lawsuits still pending, the company is expected to lose as much as $2-$3 billion and possibly more.
The source of all of these lawsuits has been linked to the drug’s main active ingredient, drospirenone. Drospirenone is a fourth generation synthetic progestin that research has proven is extremely dangerous. For a time, it appeared as if the blood clots linked to drospirenone would cause the FDA to issue a recall on the drug for safety reasons. Unfortunately, the FDA decided to keep Yaz on the market with only stricter warnings. Chances are Bayer is in for a long list of lawsuits to continue until they consider pulling Yaz off the shelves on their own.